Know2eat

Acetyl-L-carnitine

Amino Acids & Proteins

What acetyl-l-carnitine may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedCognitive functionLimited evidence· 1 source

Then, in order

3 things to know first — allergies, interactions and limits

About Acetyl-L-carnitine

The acetylated form of carnitine, which crosses the blood-brain barrier more readily than carnitine itself. Sold for cognition and nerve health rather than for fat metabolism.

Acetyl-L-carnitine has a genuinely different profile from plain carnitine, because the acetyl group allows central nervous system entry and provides acetyl units for acetylcholine synthesis. The clinical literature is old and mixed: a meta-analysis of trials in mild cognitive impairment and early Alzheimer disease reported small benefits, though most of those trials were conducted in the 1980s and 1990s to standards that would not pass today. The strongest signal is in painful diabetic neuropathy, where trials at 2–3 g/day report reduced pain and some improvement in nerve conduction.

Sold as
Capsule, Tablet, Powder
Standardised to
Grams of acetyl-L-carnitine, sometimes as the hydrochloride salt — a product without this marker may not resemble what was studied.
Also known as
ALCAR, ALC, Acetylcarnitine

Regulation: Sold as a dietary supplement in the US with no pre-market efficacy review, and available as a prescription medicine for peripheral neuropathy in some European countries.

What the research used

The amounts, forms and durations published trials of Acetyl-L-carnitine actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Painful diabetic neuropathy

    2–3 g

    Limited

    Divided doses daily · 6–12 months

    Trials report reduced pain scores and some improvement in nerve fibre measures. Several were industry-supported and the field has not produced a definitive large trial.

  • Studied for Cognitive decline in older adults

    1.5–3 g

    Limited

    Divided doses daily · 3–12 months

    Doses from trials mostly conducted decades ago in mild cognitive impairment and early Alzheimer disease. Modern replication is essentially absent.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

None of the timings below were directly compared in a trial. They reflect how the research happened to dose, or what the pharmacology implies — which is not the same as a timing being better.

  • Split through the day

    Not enough

    Divided across the day in trial protocols, and often taken earlier in the day because some people report it is stimulating. Neither has been tested as a variable.

    Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.

The evidence in depth

Best supported: Limited

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Cognitive function

Brain & Cognitive Health
Limited evidence

Meta-analysis of older trials in mild cognitive impairment and early Alzheimer disease reports small benefits on clinical and psychometric measures. The trials are old, small and heterogeneous, and no recent large trial has confirmed the finding.

What may be going on: The acetyl group is a substrate for acetylcholine synthesis and acetyl-L-carnitine supports mitochondrial fatty acid transport in neurons, though neither has been shown to mediate the clinical effect.

Limited evidence. Early human work, or mostly lab and animal research.

View the 1 source

Deep research mode adds each paper’s own conclusion and stated limitations.

Mood

Mental Wellbeing
Limited evidence

A meta-analysis of small trials reported reduced depressive symptoms with acetyl-L-carnitine, with effect sizes comparable to antidepressants in the included studies and notably lower adverse effects. The trials are small and mostly from a small number of groups.

Limited evidence. Early human work, or mostly lab and animal research.

View the 2 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Energy metabolism

Energy & Metabolism
Not enough evidence

Trials in chronic fatigue and in age-related fatigue report inconsistent results. There is not enough evidence to support a general energy claim.

Not enough evidence. Not enough human research to say anything useful yet.

View the 2 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Worth knowing

    Trimethylamine N-oxide production

    As a carnitine compound it is subject to the same gut bacterial conversion to trimethylamine and then to trimethylamine N-oxide, a metabolite associated with cardiovascular risk in cohort studies.

  • Interaction

    Warfarin and thyroid hormone

    Interacts withWarfarin, levothyroxine

    Case reports describe raised INR with carnitine compounds and warfarin. Acetyl-L-carnitine has also been reported to interfere with thyroid hormone action at the receptor level, which matters for anyone on thyroid replacement.

  • Worth knowing

    Seizure threshold and agitation

    Carnitine compounds have been associated with increased seizure activity in susceptible people, and agitation or restlessness is a common complaint at higher doses.

Evidence ratings on this page: 2 limited evidence, 1 not enough evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take Acetyl-L-carnitine, or a dose to follow.